by Christine Stackhouse | Jan 2, 2025
Wiggin and Dana is pleased to announce that Partner Michael Menapace has been recognized in the Lexology Index: Thought Leaders: USA 2025 report. Thought Leaders: USA brings together the insight, expertise and wisdom of some of the USA’s foremost lawyers and...
by Jennifer Hill | Dec 23, 2024
Wiggin and Dana recently represented Skyview Innovations, a market leader in strategy, design and deployment of Immersive Experiences, in connection with its acquisition of Hovercraft, which specializes in immersive experiences, retail, 3D, interactive and design....
by Jennifer Hill | Dec 20, 2024
Wiggin and Dana recently represented BioArctic AB (publ) (Nasdaq Stockholm: BIOA) in connection with its global license agreement with Bristol Myers Squibb (NYSE: BMY) for BioArctic’s PyroGlutamate-amyloid-beta (PyroGlu-Aβ) antibody program, including BAN1503 and...
by Christine Stackhouse | Dec 17, 2024
Partner Jeff Babbin was reappointed by Chief Justice Raheem L. Mullins to serve a new two-year term on the Connecticut Advisory Committee on Appellate Rules. Jeff has served on the Committee since his initial appointment in 2015. The Committee advises the Connecticut...
by Jennifer Hill | Dec 12, 2024
Wiggin and Dana recently represented Veradermics, Incorporated, a late clinical-stage aesthetics and dermatology-focused biopharmaceutical company, in its $75 million Series B financing. The financing was led by Suvretta Capital Management and included new investors...
